Global HealthTech Secondary Share market growing rapidly, expected to reach $26.4 Billion by 2028

Exec Summary:

The size of the healthtech secondary share sale market is growing rapidly. In 2021, the market was valued at $10.9 billion, and it is expected to reach $26.4 billion by 2028.

This growth is being driven by a number of factors, including the increasing number of healthtech companies going public, the growing demand for secondary liquidity, and the increasing sophistication of the healthtech investment community.

The secondary share sale market allows investors to buy and sell shares of privately held healthtech companies. This can be a valuable way for investors to gain exposure to promising healthtech companies that are not yet publicly traded. The market is also becoming increasingly liquid, making it easier for investors to buy and sell shares.

The growth of the healthtech secondary share sale market is being driven by a number of factors. First, the number of healthtech companies going public is increasing. In 2021, there were 180 healthtech IPOs, up from 120 in 2020. This increase in IPO activity is providing more opportunities for investors to buy shares of healthtech companies.

Second, the demand for secondary liquidity is growing. This is because many investors are looking for ways to buy and sell shares of privately held healthtech companies without having to wait for an IPO. The secondary share sale market provides a way for these investors to do so.

Third, the healthtech investment community is becoming increasingly sophisticated. This is leading to more institutional investors, such as hedge funds and private equity firms, entering the market. These investors are bringing with them more capital and expertise, which is helping to drive growth in the market.

The growth of the healthtech secondary share sale market is a positive development for the healthtech industry. It provides investors with more opportunities to invest in promising healthtech companies, and it helps to create liquidity in the market. This can lead to increased investment in healthtech, which can help to accelerate innovation and improve patient care.

Engage with the HealthTech Community

HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb

HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk

HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital

Introduction to the secondary share sale market

A secondary share sale market is a marketplace where investors can buy and sell shares of privately held companies. These shares are not traded on a public exchange, so they are not as liquid as shares of publicly traded companies. However, the secondary share sale market can be a valuable way for investors to gain exposure to promising private companies.

The secondary share sale market is often referred to as the "grey market" because it is not regulated by the same rules as the public stock market. This can make it a riskier investment, but it also offers the potential for higher returns.

There are a few different ways to participate in the secondary share sale market. One way is to use a broker who specializes in trading private shares. Another way is to find a private placement memorandum (PPM) for a company that is looking to sell shares. PPMs are documents that provide information about the company and the shares being offered.

When buying shares in the secondary share sale market, it is important to do your research and understand the risks involved. You should also make sure that you are comfortable with the illiquidity of the market.

Here are some of the key features of the secondary share sale market:

• It is a marketplace for trading shares of privately held companies.

• The shares are not traded on a public exchange, so they are not as liquid as shares of publicly traded companies.

• The market is often referred to as the "grey market" because it is not regulated by the same rules as the public stock market.

• There are a few different ways to participate in the market, including using a broker or finding a private placement memorandum (PPM).

• It is important to do your research and understand the risks involved before participating in the market.

The secondary share sale market can be a valuable way for investors to gain exposure to promising private companies. However, it is important to understand the risks involved before participating in the market.

Future of the healthtech secondary share sale market

The future of the healthtech secondary share sale market is bright. The market is expected to grow rapidly in the coming years, driven by a number of factors, including:

• The increasing number of healthtech companies going public.

• The growing demand for secondary liquidity.

• The increasing sophistication of the healthtech investment community.

The increasing number of healthtech companies going public is a major driver of growth in the secondary share sale market. As more healthtech companies go public, there will be more shares available for trading in the secondary market. This will make it easier for investors to buy and sell shares of healthtech companies, which will drive growth in the market.

The growing demand for secondary liquidity is another major driver of growth in the secondary share sale market. Many investors are looking for ways to buy and sell shares of privately held healthtech companies without having to wait for an IPO. The secondary share sale market provides a way for these investors to do so.

The increasing sophistication of the healthtech investment community is also driving growth in the secondary share sale market. As more institutional investors, such as hedge funds and private equity firms, enter the market, they are bringing with them more capital and expertise. This is helping to drive growth in the market.

Overall, the future of the healthtech secondary share sale market is bright. The market is expected to grow rapidly in the coming years, driven by a number of factors. This is good news for investors who are looking to gain exposure to the promising healthtech industry.

Here are some of the trends that are expected to shape the future of the healthtech secondary share sale market:

• The rise of digital health. Digital health is a rapidly growing segment of the healthtech industry. As digital health companies continue to grow, there will be a growing demand for secondary liquidity in this sector.

• The increasing importance of data. Data is becoming increasingly important in the healthtech industry. As healthtech companies collect and analyze more data, there will be a growing demand for secondary liquidity in this sector.

• The emergence of new technologies. New technologies, such as artificial intelligence and machine learning, are being used to develop innovative healthtech solutions. As these technologies continue to develop, there will be a growing demand for secondary liquidity in this sector.

The healthtech secondary share sale market is a dynamic and evolving market. The trends mentioned above are just a few of the factors that are expected to shape the market in the years to come. Investors who are looking to gain exposure to the promising healthtech industry should keep an eye on these trends.

Engage with the HealthTech Community

HealthTech M&A Newsletter from Nelson Advisors - Market Insights & Analysis for Founders & Investors. Subscribe today! https://lnkd.in/e5hTp_xb

HealthTech M&A Advisory by Founders for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk

HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Visit https://www.healthcare.digital